History
-
The new plant construction project was officially launched.

2017
-
The administrative office building was completed, and the administrative department moved to the new building;

2014
-
Started the process of transformation and upgrading, and developed peptides;

2014
-
Passed the EU EDQM GMP site inspection and the US FDA GMP site inspection, the company's products officially entered the European and American regulated markets;

2010
-
Passed the Australian TGA audit;

2009
-
Won the title of "National High-tech Enterprise" and became one of the first enterprises in the Paojiang Industrial Zone to pass the national high-tech enterprise evaluation;

2008
-
Obtained the drug production license and changed its name to Zhejiang Supor Pharmaceuticals Co., Ltd.;
2004
-
Firstly passed the national GMP certification and started to produce and sell Supor pharmaceuticals raw materials;
2004
-
Established Zhejiang Yiyuan Pharmaceuticals Chemical Co., Ltd. to produce pharmaceuticals intermediates;
